Zymeworks Inc (NAS:ZYME)
$ 14.5 0 (0%) Market Cap: 998.72 Mil Enterprise Value: 721.77 Mil PE Ratio: 0 PB Ratio: 2.75 GF Score: 73/100

Q1 2024 Zymeworks Inc Earnings Call Transcript

May 02, 2024 / 08:30PM GMT
Release Date Price: $9 (+2.74%)
Operator

Thank you for standing by. This is the conference operator. Welcome to Zymeworks's first-quarter 2024 results conference call and webcast. (Operator Instructions)

I would now like to turn the conference over to Shrinal Inamdar, Director of Investor Relations. Shrinal, please go ahead.

Shrinal Inamdar
Zymeworks Inc - Director, Investor Relations

Thank you, operator. Good afternoon, I'd like to welcome you to our first-quarter 2024 results conference call.

Before we begin, I'd like to remind you that we'll be making a number of forward-looking statements during this call, including without limitation, those forward-looking statements identified in our size and the accompanying or commentary. Forward-looking statements are based upon our current expectations and various assumptions, and are subject to the usual risks and uncertainties associated with companies in our industry, and at our stage of development. For discussion of these risks and uncertainties, we refer you to our latest SEC filings as found on our website and as filed with the SEC

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot